John A Carter

John A Carter

Pharmerit International - / Netherlands
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4969600
person_outline John A Carter's MOST POPULAR ARTICLES
1-) Estimating the global prevalence of transthyretin familial amyloid polyneuropathyHH Schmidt, M Waddington‐Cruz, MF Botteman, JA Carter, AS Chopra, ...Muscle & nerve 57 (5), 829-837, 20181952018
2-) Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case seriesM Waddington-Cruz, H Schmidt, MF Botteman, JA Carter, M Stewart, ...Orphanet journal of rare diseases 14 (1), 34, 2019722019
3-) Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agentsX Gao, D Wendling, MF Botteman, JA Carter, S Rao, M CifaldiJournal of medical economics 15 (6), 1054-1063, 2012562012
4-) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a cost-effectiveness analysisSJ Snedecor, JA Carter, S Kaura, MF BottemanJournal of medical economics 16 (1), 19-29, 2013482013
5-) Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis CX Gao, JM Stephens, JA Carter, S Haider, VK RustgiExpert review of pharmacoeconomics & outcomes research 12 (3), 335-343, 2012462012